South Korea

Healthcare spending in South Korea is expected to increase from KRW75,117bn (US$58.9bn) in 2009 to KRW84,053bn (US$80.1bn) in 2010. Due to the strengthening won, this equates to growth... 2010-01-25

South Korea's drug companies spend over 40% of turnover on promotional, advertising and marketing activities. This contradicts one of BMI's core views for the pharmaceutical and healthcare... 2009-04-14

A scientific paper on a diabetes gene therapy written by South Korean scientists in 2000 has been retracted by the prestigious journal Nature. BMI notes that this is the second time... 2009-04-03

Boehringer Ingleheim is outpacing the South Korean over-the-counter (OTC) medicine sector. The German company's sales increased 1.9% in the first half of 2008, while most other competitors... 2008-08-13

Ties between South Korea and Azerbaijan have been strengthened with a proposal for the creation of a joint venture to develop pharmaceuticals. The deal was brokered by the countries'... 2008-05-21

The South Korean authorities have pushed back a decision to include MSD Korea's cervical cancer vaccine, Gardasil, in the national immunisation programme. BMI believes the development... 2008-05-20

Competition in South Korea's US$6bn generic drug sector is set to increase after one of the leading global players announced plans to break ties with its local partner and go it alone.... 2008-04-24